Showing results (3061-3070 of 3,091) with videos related to

Sort By:
Pageof 310
Drug Safety|April 9, 2024
Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization StrategiesJoanne Treacy, Elaine H Morrato, Robert Horne, et al.
Drug Safety|March 27, 2024
Fatal Intoxications with Zopiclone-A Cause for Concern?Lova Tralla, Sara Gustavsson, Carl Söderberg, et al.
Drug Safety|September 24, 2024
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription DrugsVincent L Chen, Don C Rockey, Einar S Bjornsson, et al.
Drug Safety|August 2, 2024
The Methodological Quality of Observational Studies Examining the Risk of Pregnancy Drug Use on Congenital Malformations Needs Substantial Improvement: A Cross-Sectional SurveyYulong Jia, Jing Wang, Chunrong Liu, et al.
Drug Safety|August 5, 2024
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and SimulationsGerd Rippin, Héctor Sanz, Wilhelmina E Hoogendoorn, et al.
Drug Safety|April 26, 2025
Impact of Batoclimab Treatment on LDL-C with and Without Coadministration of Atorvastatin: Results from a Phase I Randomized Study in Healthy ParticipantsThomas Hardy, Su Liang, Philip Tedeschi, et al.
Drug Safety|March 3, 2025
Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing MushroomsAhmed Al-Imam, Riccardo Lora, Marek A Motyka, et al.
Drug Safety|March 2, 2025
Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022Haoxin Le, Per Sindahl, Morten Andersen, et al.
Drug Safety|June 21, 2024
Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping ReviewJenine Shafi, Maneet K Virk, Emma Kalk, et al.
Drug Safety|June 1, 2024
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 StudiesAdi Mor, Scott Friedman, Sharon Hashmueli, et al.
Pageof 310